SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Obsidian Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates

Presented positive updated efficacy and pooled safety data on amsoki-cel in advanced melanoma at the

OBX

Related stories